| TEMPUS AI INC. DL-,01 |
| USA |
| Gesundheit |
| US88023B1035 / A40EDP |
| F3M (Frankfurt) / TEM (NASDAQ) |
| FRA:F3M, ETR:F3M, F3M:GR, NASDAQ:TEM |
| - |
| https://www.tempus.com/ |
|
Tempus AI, Inc. is a health technology company focused on applying artificial intelligence to precision medicine and clinical decision support. Founded in 2015, the company builds and operates a large..
>Volltext.. |
| 7811.29 Mio. EUR |
| 8303.04 Mio. EUR |
| 934.13 Mio. EUR |
| -125.1 Mio. EUR |
| -172.31 Mio. EUR |
| -1 EUR |
| 1128.99 Mio. EUR |
| 554.36 Mio. EUR |
| -186.4 Mio. EUR |
| 2.17 |
| 63.75% |
| 73.97% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 10.921.189 USD. |
| TEMPUS AI, TEMPUS AI′S, TEMPUS AI S |
| 18.02.26 |